ArticleCommunications biology2021

Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models.

Jack Wuyang Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.